Home/Filings/4/0001214659-18-000185
4//SEC Filing

Brister Mark 4

Accession 0001214659-18-000185

CIK 0001427570other

Filed

Jan 3, 7:00 PM ET

Accepted

Jan 4, 4:10 PM ET

Size

5.0 KB

Accession

0001214659-18-000185

Insider Transaction Report

Form 4
Period: 2018-01-02
Brister Mark
VP of Research and Development
Transactions
  • Award

    Common Stock (Restricted Stock Award)

    2018-01-02+65,00065,000 total
Footnotes (1)
  • [F1]The Restricted Shares shall vest as to one-half of the Shares underlying the Award on each of the first and second anniversary of the Grant Date, subject to the grantee's continued status as a Service Provider with the Company through the applicable vesting date.

Issuer

OBALON THERAPEUTICS INC

CIK 0001427570

Entity typeother

Related Parties

1
  • filerCIK 0001323223

Filing Metadata

Form type
4
Filed
Jan 3, 7:00 PM ET
Accepted
Jan 4, 4:10 PM ET
Size
5.0 KB